Tag: HighTide Therapeutics Inc.
HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study...
HighTide Therapeutics Inc. (HighTide), a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive diseases, today announced the...
HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance...
Global biopharmaceutical company focusing on metabolic and digestive diseasesProceeds to fund clinical and business development
HighTide Therapeutics Inc. (HighTide),...